Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × sargramostim × Head & Neck × Clear all

Phase

Status

Completed 5 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5 Plasma cell 3 Other hematologic neoplasm 3 Genitourinary 2 Dermatologic 2 Breast 2 Thoracic 1 Other solid neoplasm 1 Myeloid 1 Head & Neck 1 Gastrointestinal 1 CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 104 Docetaxel 43 Radiotherapy 37 Radiotherapy, Intensity-Modulated 33 Fluorouracil 29 Gemcitabine 27 toripalimab 19 Cetuximab 19 camrelizumab 18 apatinib 18 Paclitaxel 16 Drug Therapy 15 Carboplatin 15 Capecitabine 14 nimotuzumab 12 sintilimab 11 Chemoradiotherapy 11 pembrolizumab 10 durvalumab 10 Surveys and Questionnaires 10 Endostatins 10 Blood Specimen Collection 9 nedaplatin 8 endostar protein 8 Surgical Procedures, Operative 8 Induction Chemotherapy 8 Radiation 7 Nivolumab 7 Cyclophosphamide 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05075122 2022-03-09

FOCUS

Martin-Luther-Universität Halle-Wittenberg

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡